Ion Beam Applications SA - Asset Resilience Ratio
Ion Beam Applications SA (IBAB) has an Asset Resilience Ratio of 0.03% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Ion Beam Applications SA's Asset Resilience Ratio has changed over time. Check IBAB PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Ion Beam Applications SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see IBAB company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €172.00K | 0.03% |
| Total Liquid Assets | €172.00K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: Ion Beam Applications SA maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ion Beam Applications SA Industry Peers by Asset Resilience Ratio
Compare Ion Beam Applications SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Edwards Lifesciences Corp
NYSE:EW |
Medical Devices | 9.20% |
|
DexCom Inc
NASDAQ:DXCM |
Medical Devices | 19.55% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212 |
Medical Devices | 6.09% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Theradiag SA
PA:ALTHE |
Medical Devices | 15.59% |
|
Corentec Co Ltd
KQ:104540 |
Medical Devices | 2.80% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Annual Asset Resilience Ratio for Ion Beam Applications SA (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Ion Beam Applications SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.07% | €416.00K ≈ $486.35K |
€616.10 Million ≈ $720.29 Million |
+0.02pp |
| 2023-12-31 | 0.05% | €309.00K ≈ $361.25K |
€597.53 Million ≈ $698.57 Million |
+0.03pp |
| 2022-12-31 | 0.03% | €160.00K ≈ $187.06K |
€623.90 Million ≈ $729.40 Million |
+0.01pp |
| 2021-12-31 | 0.02% | €82.00K ≈ $95.87K |
€546.05 Million ≈ $638.39 Million |
-0.29pp |
| 2020-12-31 | 0.31% | €1.58 Million ≈ $1.84 Million |
€511.00 Million ≈ $597.41 Million |
+0.23pp |
| 2019-12-31 | 0.08% | €320.00K ≈ $374.11K |
€425.11 Million ≈ $497.00 Million |
+0.05pp |
| 2018-12-31 | 0.02% | €95.00K ≈ $111.06K |
€407.24 Million ≈ $476.11 Million |
-0.89pp |
| 2017-12-31 | 0.92% | €3.05 Million ≈ $3.56 Million |
€332.52 Million ≈ $388.75 Million |
+0.56pp |
| 2016-12-31 | 0.35% | €1.35 Million ≈ $1.57 Million |
€380.62 Million ≈ $444.98 Million |
+0.25pp |
| 2015-12-31 | 0.11% | €422.00K ≈ $493.36K |
€395.35 Million ≈ $462.21 Million |
-0.02pp |
| 2014-12-31 | 0.12% | €381.00K ≈ $445.43K |
€307.06 Million ≈ $358.98 Million |
-0.01pp |
| 2013-12-31 | 0.13% | €367.00K ≈ $429.06K |
€281.75 Million ≈ $329.40 Million |
+0.10pp |
| 2012-12-31 | 0.03% | €121.00K ≈ $141.46K |
€386.20 Million ≈ $451.51 Million |
-0.17pp |
| 2011-12-31 | 0.21% | €1.02 Million ≈ $1.20 Million |
€498.01 Million ≈ $582.23 Million |
-0.08pp |
| 2010-12-31 | 0.29% | €1.53 Million ≈ $1.79 Million |
€528.21 Million ≈ $617.53 Million |
-0.25pp |
| 2009-12-31 | 0.54% | €2.59 Million ≈ $3.03 Million |
€479.64 Million ≈ $560.75 Million |
+0.09pp |
| 2008-12-31 | 0.45% | €2.27 Million ≈ $2.66 Million |
€509.52 Million ≈ $595.68 Million |
-0.13pp |
| 2007-12-31 | 0.57% | €1.86 Million ≈ $2.17 Million |
€324.44 Million ≈ $379.30 Million |
+0.47pp |
| 2006-12-31 | 0.11% | €284.00K ≈ $332.03K |
€266.87 Million ≈ $312.00 Million |
-13.04pp |
| 2005-12-31 | 13.15% | €26.66 Million ≈ $31.17 Million |
€202.75 Million ≈ $237.04 Million |
-15.79pp |
| 2004-12-31 | 28.94% | €99.90 Million ≈ $116.79 Million |
€345.22 Million ≈ $403.60 Million |
+28.78pp |
| 2003-12-31 | 0.16% | €818.00K ≈ $956.33K |
€500.56 Million ≈ $585.21 Million |
-5.56pp |
| 2002-12-31 | 5.72% | €39.47 Million ≈ $46.15 Million |
€690.15 Million ≈ $806.86 Million |
+1.01pp |
| 2001-12-31 | 4.71% | €36.03 Million ≈ $42.12 Million |
€764.48 Million ≈ $893.75 Million |
-9.33pp |
| 2000-12-31 | 14.04% | €105.72 Million ≈ $123.60 Million |
€753.05 Million ≈ $880.39 Million |
-- |
About Ion Beam Applications SA
Ion Beam Applications SA designs, produces, and markets solutions for cancer diagnosis and treatments in Belgium, the United States, and internationally. It operates through Proton Therapy and Other Accelerators; and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems. Thi… Read more